{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:33:04Z","timestamp":1790346784968,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jaad.2005.04.055","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T07:29:37Z","timestamp":1124954977000},"page":"578-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Pulse versus continuous terbinafine for onychomycosis: A randomized, double-blind, controlled trial"],"prefix":"10.1016","volume":"53","author":[{"given":"Erin M.","family":"Warshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra D.","family":"Fett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna E.","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Carver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Zielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Lederle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.04.055_bib1","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions","volume":"133","author":"Elewski","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.1974.tb06718.x","article-title":"Onychomycosis in elderly chiropody patients","volume":"91","author":"English","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00449429","article-title":"Quality of life in persons with onychomycosis","volume":"2","author":"Lubeck","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaad.2005.04.055_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7547\/87507315-87-11-512","article-title":"Onychomycosis. Baseline results of an observational study","volume":"87","author":"Schein","year":"1997","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jaad.2005.04.055_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-4362.1997.00163.x","article-title":"The effect of toenail onychomycosis on patient quality of life","volume":"36","author":"Elewski","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib6","unstructured":"Rosenbach M, Schneider JE. The burden of onychomycosis in the Medicare population. Health Economic Research, Inc. Sandoz Pharmaceuticals Corporation."},{"key":"10.1016\/j.jaad.2005.04.055_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2133.1994.tb06092.x","article-title":"Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective","volume":"130","author":"Einarson","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.1994.tb06093.x","article-title":"A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group","volume":"130","author":"Arikian","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0149-2918(96)80225-6","article-title":"Pharacoeconomic analysis of oral therapies for onychomycosis: a US model","volume":"18","author":"Marchetti","year":"1996","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2005.04.055_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00019053-200119040-00007","article-title":"Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis","volume":"19","author":"Jansen","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2005.04.055_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-2918(97)80140-3","article-title":"Pharmacoeconomic applications of meta-analysis for single groups using antifungal onychomycosis lacquers as an example","volume":"19","author":"Einarson","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2005.04.055_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00019053-199813020-00007","article-title":"Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis","volume":"13","author":"Gupta","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2005.04.055_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00019053-200119100-00002","article-title":"Which antifungal agent for onychomycosis? A pharmacoeconomic analysis","volume":"19","author":"Joish","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2005.04.055_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00019053-200119030-00005","article-title":"Cost of treatment for onychomycosis. Data from a 9-month observational study","volume":"19","author":"Stier","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2005.04.055_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00019053-200220050-00003","article-title":"Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (diflucan) in the treatment of patients with toenail onychomycosis","volume":"20","author":"Salo","year":"2002","journal-title":"Pharmacoeconomics"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib16","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0190-9622(98)70488-8","article-title":"Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials","volume":"38","author":"Bootman","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2133.1998.02463.x","article-title":"A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice","volume":"139","author":"Humphrey","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1346-8138.1996.tb04009.x","article-title":"Intermittent therapy with terbinafine for dermatophyte toe onychomycosis: a new approach","volume":"23","author":"Alpsoy","year":"1996","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0190-9622(96)80057-0","article-title":"Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine with continuous terbinafine treatment and intermittent itraconazole therapy","volume":"34","author":"Tosti","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000017990","article-title":"Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up","volume":"197","author":"Tosti","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2005.04.055_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mjd.2001.110644","article-title":"Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis","volume":"44","author":"Gupta","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib22","series-title":"Nails: Therapy, diagnosis, surgery","first-page":"42","article-title":"Basic science of the nail unit","author":"Fleckman","year":"1990"},{"key":"10.1016\/j.jaad.2005.04.055_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.318.7190.1031","article-title":"Double blind, randomized study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group","volume":"318","author":"Evans","year":"1999","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib24","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0190-9622(98)70486-4","article-title":"Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg\/day versus itraconazole 200 mg\/day","volume":"38","author":"De Backer","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archderm.1996.03890250044008","article-title":"Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole","volume":"132","author":"De Doncker","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib26","first-page":"230","article-title":"A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychymycosis","volume":"136","author":"Havu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0190-9622(97)70286-X","article-title":"A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail","volume":"36","author":"Odom","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib28","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150, 300 or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib29","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0190-9622(98)70485-2","article-title":"Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails","volume":"38","author":"Brautigam","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1995.01690200057011","article-title":"Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin","volume":"131","author":"Hofmann","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0190-9622(95)91454-4","article-title":"Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis","volume":"32","author":"Faergemann","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib32","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0190-9622(96)90062-6","article-title":"Diagnostic techniques for confirming onychomycosis","volume":"35","author":"Elewski","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib33","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.3.5563.464","article-title":"Mycological and clinical evaluation of griseofulvin for chronic onychomycosis","volume":"3","author":"Davies","year":"1967","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2005.04.055_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.1985.tb02338.x","article-title":"A comparative double-blind study of ketoconazole and griseofulvin in dermatophytosis","volume":"112","author":"Hay","year":"1985","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib36","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0190-9622(98)70492-X","article-title":"Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail","volume":"38","author":"Ling","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.04.055_bib37","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0190-9622(08)81837-3","article-title":"New approaches to the treatment of onychomycosis","volume":"29","author":"Roseeuw","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00007611-199512000-00006","article-title":"An evaluation of the safety and efficacy of fluconazole in the treatment of onychomycosis","volume":"88","author":"Smith","year":"1995","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2005.04.055_bib39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-4362.1995.tb03600.x","article-title":"Open randomized comparison of itraconazole versus terbinafine in onychomycosis","volume":"34","author":"Arenas","year":"1993","journal-title":"Int J Dermatol"},{"issue":"Suppl 39","key":"10.1016\/j.jaad.2005.04.055_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1992.tb00007.x","article-title":"Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial","volume":"126","author":"Goodfield","year":"1992","journal-title":"Br J Dermatol"},{"issue":"Suppl 39","key":"10.1016\/j.jaad.2005.04.055_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.1992.tb00008.x","article-title":"A randomized treatment duration-finding study of terbinafine in onychomycosis","volume":"126","author":"van der Schroeff","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib42","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archderm.134.12.1551","article-title":"How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data","volume":"134","author":"Epstein","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archderm.138.6.811","article-title":"Oral treatments for toenail onychomycosis: a systematic review","volume":"138","author":"Crawford","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2133.2002.04825.x","article-title":"Terbinafine in fungal infections of the nails: a meta-analysis of randomised clinical trials","volume":"137","author":"Haugh","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/000155599750011020","article-title":"Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis","volume":"79","author":"Degreef","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2005.04.055_bib46","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0190-9622(97)70111-7","article-title":"Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial","volume":"37","author":"Drake","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2133.2002.04606.x","article-title":"Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial","volume":"146","author":"Farkas","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7547\/87507315-91-3-127","article-title":"Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations","volume":"91","author":"Pollak","year":"2001","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jaad.2005.04.055_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2133.1997.6661651.x","article-title":"Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group","volume":"136","author":"Tausch","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2133.1996.tb15653.x","article-title":"A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg\/day vs itraconazole 200 mg\/day\u2014a double-blind comparative trial","volume":"143","author":"De Backer","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.1996.tb15654.x","article-title":"German randomized double-blind multicenter comparison of terbinafine and itraconazole for the treatment of toenail tinea infections","volume":"134","author":"Brautigam","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/0001555555776669","article-title":"Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-up","volume":"77","author":"Svejgaard","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2005.04.055_bib53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2230.1995.tb01353.x","article-title":"Nail incorporation kinetics of terbinafine in onychomycosis patients","volume":"20","author":"Schatz","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.140.6.691","article-title":"The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine","volume":"140","author":"Zaias","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.04.055_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1439-0507.1995.tb00037.x","article-title":"Clinical and pharmacokinetic investigations of oral terbinafine in patients with tinea unguium","volume":"38","author":"Matsumoto","year":"1995","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2005.04.055_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7547\/87507315-87-12-557","article-title":"Surgical treatment of mycotic toenails","volume":"87","author":"McInnes","year":"1997","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jaad.2005.04.055_bib57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1468-3083.2002.00589.x","article-title":"Onychomycosis: strategies to improve efficacy and reduce recurrence","volume":"16","author":"Gupta","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2005.04.055_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1067\/mjd.2002.119674","article-title":"Reactivity to trichophytin antigen in patients with onychomycosis: effect of terbinafine","volume":"46","author":"Elewski","year":"2002","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205013381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205013381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:38:28Z","timestamp":1759268308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205013381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0190962205013381"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.04.055","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulse versus continuous terbinafine for onychomycosis: A randomized, double-blind, controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}